UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 805

Sortiert nach

Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study

Blood, 2020-08, Vol.136 (6), p.674-683

2020

Link zum Volltext

Verfügbarkeit prüfen

Venetoclax Plus Gilteritinib for FLT3 -Mutated Relapsed/Refractory Acute Myeloid Leukemia

Journal of clinical oncology, 2022-12, Vol.40 (35), p.4048-4059

2022

Link zum Volltext

Verfügbarkeit prüfen

The RNA Modification Database, RNAMDB: 2011 update

Nucleic acids research, 2011-01, Vol.39 (Database issue), p.D195

2011

Link zum Volltext

Verfügbarkeit prüfen

Lightest to the Right: An Apparently Anomalous Displacement in Irish

Linguistic inquiry, 2016-04, Vol.47 (2), p.169-234

2016

Link zum Volltext

Verfügbarkeit prüfen

Reliability of Cell-Free DNA and Targeted NGS in Predicting Chromosomal Abnormalities of Patients With Myeloid Neoplasms

Frontiers in oncology, 2022-06, Vol.12, p.923809-923809

2022

Link zum Volltext

Verfügbarkeit prüfen

Measurable Residual Disease in High-Risk Acute Myeloid Leukemia

Cancers, 2022-03, Vol.14 (5), p.1278

2022

Link zum Volltext

Verfügbarkeit prüfen

A methodology to define risk matrices – Application to inland water ways autonomous ships

International Journal of Naval Architecture and Ocean Engineering, 2022, 14(0), , pp.1-16

2022

Link zum Volltext

Verfügbarkeit prüfen

Venetoclax and hypomethylating agents (HMAs) induce high response rates in MDS, including patients after HMA therapy failure

Blood advances, 2020-07, Vol.4 (13), p.2866-2870

2020

Link zum Volltext

Verfügbarkeit prüfen

An Aminoacyl-tRNA Synthetase That Specifically Activates Pyrrolysine

Proceedings of the National Academy of Sciences - PNAS, 2004-08, Vol.101 (34), p.12450-12454

2004

Link zum Volltext

Verfügbarkeit prüfen

Isatuximab monotherapy in patients with refractory T‐acute lymphoblastic leukemia or T‐lymphoblastic lymphoma: Phase 2 study

Cancer medicine (Malden, MA), 2022-03, Vol.11 (5), p.1292-1298

2022

Link zum Volltext

Verfügbarkeit prüfen

CML-047 Post Hoc Analysis of Responses to Ponatinib in Patients With Chronic-Phase Chronic Myeloid Leukemia (CP-CML) by Baseline BCR::ABL1 Level and Baseline Mutation Status in the OPTIC Trial

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S285-S286

2022

Link zum Volltext

Verfügbarkeit prüfen

First‐in‐human study of JNJ‐67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome

Clinical and translational science, 2024-03, Vol.17 (3), p.e13742-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

A Truncated Aminoacyl-tRNA Synthetase Modifies RNA

Proceedings of the National Academy of Sciences - PNAS, 2004-05, Vol.101 (20), p.7536-7541

2004

Link zum Volltext

Verfügbarkeit prüfen

Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors

Heliyon, 2023-05, Vol.9 (5), p.e16261-e16261, Article e16261

2023

Link zum Volltext

Verfügbarkeit prüfen

The RNA Modification Database: 1999 update

Nucleic acids research, 1999-01, Vol.27 (1), p.196

1999

Link zum Volltext

Verfügbarkeit prüfen

Thermal conductivity and particle agglomeration in alumina nanofluids: experiment and theory

Physical review. E, Statistical, nonlinear, and soft matter physics, 2007-12, Vol.76 (6 Pt 1), p.061203-061203, Article 061203

2007

Link zum Volltext

Verfügbarkeit prüfen

Influence of Phylogeny on Posttranscriptional Modification of rRNA in Thermophilic Prokaryotes: The Complete Modification Map of 16S rRNA of Thermus thermophilus

Biochemistry (Easton), 2006-04, Vol.45 (15), p.4888-4899

2006

Link zum Volltext

Verfügbarkeit prüfen

P1031: PRELIMINARY DATA FROM THE PHASE 1/2 STUDY OF TP‐3654, AN INVESTIGATIONAL SELECTIVE PIM1 KINASE INHIBITOR, SHOWED CYTOKINE REDUCTION AND CLINICAL RESPONSES IN RELAPSED/REFRACTORY MYELOFIBROSIS

HemaSphere, 2023-08, Vol.7 (S3), p.e42358df-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

SOS: a simple interactive program for ab initio oligonucleotide sequencing by mass spectrometry

Journal of the American Society for Mass Spectrometry, 2002-03, Vol.13 (3), p.200-203

2002

Link zum Volltext

Verfügbarkeit prüfen

S110: PHALLCON: A PHASE 3 STUDY COMPARING PONATINIB VERSUS IMATINIB IN NEWLY DIAGNOSED PH+ ALL

HemaSphere, 2023-08, Vol.7 (S3), p.e68516d0-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Influence of Temperature on tRNA Modification in Archaea: Methanococcoides burtonii (Optimum Growth Temperature [Topt], 23°C) and Stetteria hydrogenophila (Topt, 95°C)

Journal of Bacteriology, 2003-09, Vol.185 (18), p.5483-5490

2003

Link zum Volltext

Verfügbarkeit prüfen

The Small Subunit rRNA Modification Database

Nucleic acids research, 2005-01, Vol.33 (Database issue), p.D135

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 805

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(514)
Mit Volltextzugriff
(741)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(285)
Life Sciences & Biomedicine
(187)
Humans
(103)
Chemistry
(93)
Physical Sciences
(89)
Biochemistry & Molecular Biology
(74)
Biological And Medical Sciences
(67)
Female
(61)
Male
(54)
Mass Spectrometry
(51)
Social Sciences
(51)
Adult
(40)
Biochemistry
(40)
Linguistics
(38)
Technology
(38)
Fundamental And Applied Biological Sciences. Psychology
(36)
Language & Linguistics
(36)
Syntax
(35)
Medical Sciences
(33)
Middle Aged
(32)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial

Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study

Venetoclax Plus Gilteritinib for FLT3 -Mutated Relapsed/Refractory Acute Myeloid Leukemia

Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study

The RNA Modification Database, RNAMDB: 2011 update

Lightest to the Right: An Apparently Anomalous Displacement in Irish

Reliability of Cell-Free DNA and Targeted NGS in Predicting Chromosomal Abnormalities of Patients With Myeloid Neoplasms

Measurable Residual Disease in High-Risk Acute Myeloid Leukemia

A methodology to define risk matrices – Application to inland water ways autonomous ships

Venetoclax and hypomethylating agents (HMAs) induce high response rates in MDS, including patients after HMA therapy failure

An Aminoacyl-tRNA Synthetase That Specifically Activates Pyrrolysine

Isatuximab monotherapy in patients with refractory T‐acute lymphoblastic leukemia or T‐lymphoblastic lymphoma: Phase 2 study

CML-047 Post Hoc Analysis of Responses to Ponatinib in Patients With Chronic-Phase Chronic Myeloid Leukemia (CP-CML) by Baseline BCR::ABL1 Level and Baseline Mutation Status in the OPTIC Trial

First‐in‐human study of JNJ‐67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome

A Truncated Aminoacyl-tRNA Synthetase Modifies RNA

Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors

The RNA Modification Database: 1999 update

Thermal conductivity and particle agglomeration in alumina nanofluids: experiment and theory

Influence of Phylogeny on Posttranscriptional Modification of rRNA in Thermophilic Prokaryotes: The Complete Modification Map of 16S rRNA of Thermus thermophilus

P1031: PRELIMINARY DATA FROM THE PHASE 1/2 STUDY OF TP‐3654, AN INVESTIGATIONAL SELECTIVE PIM1 KINASE INHIBITOR, SHOWED CYTOKINE REDUCTION AND CLINICAL RESPONSES IN RELAPSED/REFRACTORY MYELOFIBROSIS

SOS: a simple interactive program for ab initio oligonucleotide sequencing by mass spectrometry

S110: PHALLCON: A PHASE 3 STUDY COMPARING PONATINIB VERSUS IMATINIB IN NEWLY DIAGNOSED PH+ ALL

P662: POST HOC ANALYSIS OF PATIENT RESPONSES BY T315I MUTATION STATUS FROM THE 3‐YEAR UPDATE OF THE OPTIC TRIAL: A DOSE‐OPTIMIZATION STUDY OF 3 STARTING DOSES OF PONATINIB

Influence of Temperature on tRNA Modification in Archaea: Methanococcoides burtonii (Optimum Growth Temperature [Topt], 23°C) and Stetteria hydrogenophila (Topt, 95°C)

The Small Subunit rRNA Modification Database

Suchergebnisse filtern